Supernus Pharmaceuticals Inc. (SUPN)
NASDAQ · Healthcare
Supernus Pharmaceuticals Inc. Long Term Debt 2010–2025
Supernus Pharmaceuticals Inc. annual long term debt history from 2012 to 2021. Long term debt refers to financial obligations that are due more than one year in the future.
- Supernus Pharmaceuticals Inc. long term debt as of December 31, 2021: 379.3M, a 1532.95% increase year-over-year.
- Supernus Pharmaceuticals Inc. long term debt for 2021 were 379.3M, a 1532.95% increase from 2012.
- Supernus Pharmaceuticals Inc. long term debt for 2012 were 23.2M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Supernus Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2021 | $379 |
| 2012 | $23 |
Supernus Pharmaceuticals Inc. Long Term Debt — FAQ
Supernus Pharmaceuticals Inc. (SUPN) long term debt over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SUPN's long term debt history?
The chart and table above show Supernus Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.